ENHANCEMENT OF TRANSGENE EXPRESSION FROM VIRAL-BASED VACCINE VECORS BY EXPRESSION OF SUPPRESSORS OF THE TYPE I INTERFERON RESPONSE

摘要

Viral-based vectors are genetically engineered to express inhibitors of the anti-viral immune system (e.g. inhibitors of the type I interferon response) in order to enhance transgene expression. The transgenes may encode antigens or other therapeutic agents.